These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12742933)

  • 21. [Hyperhomocysteinemia is frequent in coronary disease patients. Study of 202 patients].
    Fernández-Miranda C; Aranda JL; Gómez González P; Díaz-Rubio P; Estenoz J; Gómez de la Cámara A
    Med Clin (Barc); 1999 Oct; 113(11):407-10. PubMed ID: 10562951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
    Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
    Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Homocysteine: vascular risk factor?].
    Gil Núñez AC
    Neurologia; 2004; 19(1):1-4. PubMed ID: 14762726
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis.
    Malerba M; Gisondi P; Radaeli A; Sala R; Calzavara Pinton PG; Girolomoni G
    Br J Dermatol; 2006 Dec; 155(6):1165-9. PubMed ID: 17107384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of folic acid fortification on plasma folate and total homocysteine concentrations.
    Jacques PF; Selhub J; Bostom AG; Wilson PW; Rosenberg IH
    N Engl J Med; 1999 May; 340(19):1449-54. PubMed ID: 10320382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
    Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
    Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The plasma homocysteine, folic acid and vitamin B12 levels in young people with high risk for cardiovascular disease and its relation to metylentetrahydrofolate reductase (MTHFR) gene polymorphism].
    Klujber V; Lengyel B; Szabó T; Németh A; Dobó M
    Orv Hetil; 2005 Apr; 146(14):649-51. PubMed ID: 15889539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum folate is associated with coronary heart disease independently of homocysteine in Turkish men.
    Onat A; Hergenç G; Küçükdurmaz Z; Can G; Ayhan E; Bulur S
    Clin Nutr; 2008 Oct; 27(5):732-9. PubMed ID: 18694616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.
    Van Guelpen B; Hultdin J; Johansson I; Witthöft C; Weinehall L; Eliasson M; Hallmans G; Palmqvist R; Jansson JH; Winkvist A
    J Intern Med; 2009 Aug; 266(2):182-95. PubMed ID: 19298497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging.
    Kado DM; Karlamangla AS; Huang MH; Troen A; Rowe JW; Selhub J; Seeman TE
    Am J Med; 2005 Feb; 118(2):161-7. PubMed ID: 15694902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
    Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
    Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between plasma folate and coronary disease independent of homocysteine.
    Silberberg JS; Crooks RL; Wlodarczyk JH; Fryer JL
    Am J Cardiol; 2001 Apr; 87(8):1003-4; A5. PubMed ID: 11305995
    [No Abstract]   [Full Text] [Related]  

  • 33. Folate and cardiovascular disease. Why we need a trial now.
    Stampfer MJ; Rimm EB
    JAMA; 1996 Jun; 275(24):1929-30. PubMed ID: 8648876
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma folate adequacy as determined by homocysteine level.
    Lewis CA; Pancharuniti N; Sauberlich HE
    Ann N Y Acad Sci; 1992 Sep; 669():360-2. PubMed ID: 1444047
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum folate and risk of fatal coronary heart disease.
    Braun RD
    JAMA; 1996 Oct; 276(15):1222. PubMed ID: 8849748
    [No Abstract]   [Full Text] [Related]  

  • 36. Exclusion of a case-control study from meta-analysis.
    Hoogeveen EK; Stehouwer CD
    Mayo Clin Proc; 2009 Jun; 84(6):561; author reply 561. PubMed ID: 19483176
    [No Abstract]   [Full Text] [Related]  

  • 37. Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects.
    De Bree A; Verschuren WM; Kromhout D; Mennen LI; Blom HJ
    Int J Epidemiol; 2002 Dec; 31(6):1268-72; author reply 1271-2. PubMed ID: 12540734
    [No Abstract]   [Full Text] [Related]  

  • 38. "Polypill" to fight cardiovascular disease: interpretation of trial data is optimistic.
    Assmann G; Cullen P; Schulte H
    BMJ; 2003 Oct; 327(7418):808; discussion 809; author reply 809-10. PubMed ID: 14525891
    [No Abstract]   [Full Text] [Related]  

  • 39. Intensive glucose control and cardiovascular outcomes.
    Siebenhofer A; Jeitler K; Pieber TR; Horvath K
    Lancet; 2009 Aug; 374(9689):523; author reply 524. PubMed ID: 19683635
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary: like it and lump it? Meta-analysis using individual participant data.
    Riley RD
    Int J Epidemiol; 2010 Oct; 39(5):1359-61. PubMed ID: 20660642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.